Cytel
Cytel is a data-science CRO that provides adaptive trial design software, biostatistics, real-world evidence, and FSP services to pharmaceutical, biotechnology, and academic life sciences organizations globally.
- Company typePrivate
- Founded1987
- HeadquartersCambridge, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingSoftware
What Cytel does
Cytel is a privately held, data-science–focused contract research organization (CRO) founded in 1987 and headquartered in Cambridge, Massachusetts. The company serves pharmaceutical, biotechnology, and academic life sciences clients with an integrated offering that combines proprietary statistical software, biostatistics and biometrics services, adaptive trial design expertise, real-world evidence generation, regulatory strategy, and functional service provider (FSP) staffing. Its core software portfolio is anchored by the East Horizon™ Platform for adaptive and Bayesian trial design and simulation, supplemented by the Xact software suite (StatXact®), Enforesys for trial implementation, LiveSLR® for systematic literature reviews, Solara® for complex innovative trial designs, and OKGO® for randomization and patient management. The company also operates Axio®, a wholly owned subsidiary providing data monitoring committee services that facilitate more than 500 DMC meetings annually, and stève consultants for strategic consulting in Europe.
Cytel firmographics
Firmographics- Name
- Cytel
- Legal name
- Cytel Inc.
- Website
- https://cytel.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Cytel is a data-science CRO that provides adaptive trial design software, biostatistics, real-world evidence, and FSP services to pharmaceutical, biotechnology, and academic life sciences organizations globally.
- Ownership category
- akta.pro rank
Cytel industry classification
Industry- Product category
- Clinical Trial Design Software & CRO Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Clinical Trial Management Systems (CTMS) (HLACAOAD), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)
Keywords
Where Cytel is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices15 records
Markets served
Cytel business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Functional Service Provider (FSP): Scalable teams of experts integrated into client processes for project delivery across clinical trial phases. Provides flexible staffing and capacity management.
- Project-Based Analytical Services: Specialized expertise and end-to-end biometrics delivered on a project basis, including strategic consulting, clinical development planning, and regulatory strategy.
- Software Licensing: Enterprise software platform licenses for trial design, simulation, and implementation. Includes East Horizon, StatXact, Solara, Enforesys, and LiveSLR available through CytelStore.
- Strategic Consulting: High-value consulting engagements including regulatory strategy, market access, health economics, and clinical development strategy.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Cytel product offering
Product offeringCore offering
Cytel is a data-science CRO that sells proprietary clinical trial design and simulation software (East Horizon, StatXact, Solara, Enforesys, LiveSLR) alongside professional services including adaptive trial design consulting, biostatistics, real-world evidence generation, regulatory strategy, and functional service provider (FSP) staffing for pharmaceutical, biotech, and academic research clients.
Product overview
Cytel is a data-science focused Contract Research Organization (CRO) offering an integrated platform of clinical trial design software and strategic analytics services. The core software portfolio includes the East Horizon™ Platform for AI-enabled adaptive trial design and simulation, the Xact Software Suite (including StatXact®) for exact statistical inference, Enforesys for trial implementation and patient enrollment optimization, and LiveSLR for systematic literature reviews. These are complemented by specialized service offerings including Axio DMC Services (Data Monitoring Committee support), Real-World Evidence Solutions, Strategic Consulting, Functional Service Provider (FSP) staffing, and Project-Based Analytical Solutions. The company operates across global locations including North America (Cambridge MA headquarters, Seattle WA), Europe (Geneva, Basel, Paris, London, Rotterdam, Berlin, Stockholm, Uppsala), India (Pune, Hyderabad), and China (Shanghai, Beijing), with recent expansion into Asia Pacific.
Differentiator
Problem solved
Functional benefit
Brands
- East Horizon™ Platform: Trial design software platform for clinical trial design and simulation
- Xact software suite
- Axio®
- LiveSLR®
- Enforesys
- Solara®
- stève consultants
- OKGO®
Products and services
- East Horizon Platform
- Xact Software Suite (StatXact)
- Enforesys
- LiveSLR
- Axio DMC Services
- OKGO
- Real-World Evidence Solutions
- Strategic Consulting
- Functional Service Provider (FSP)
- Project-Based Analytical Solutions
Quantifiable outcome
- Simulation can reduce active ingredient requirements by over 37% while decreasing medication shipments
- +1 more outcomes
Companies that use Cytel
Customer profileSegments3 records
Ideal customer profiles3 records
Cytel technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature10 records
Cytel partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- OneMedNetcoreCytel was unveiled as OneMedNet's newest alliance partner. This partnership enables Cytel to leverage OneMedNet's real-world data capabilities to enhance clinical trial design and healthcare decision-making through advanced data sources and analytical methods.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Cytel competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the world's largest CRO and life sciences analytics provider, offering end-to-end clinical, RWE, and technology services that directly overlap with Cytel's biometrics, FSP, and adaptive trial design capabilities — Cytel competes as a specialized alternative to IQVIA's full-service engagements.
- ICON plc: ICON is a top-3 global CRO with strong biometrics, FSP, and adaptive trial capabilities post-PRA Health Sciences and Symphony Health acquisitions, making it a primary competitor for Cytel's project-based and FSP engagements with pharma/biotech sponsors.
- Labcorp (Covance Drug Development): Labcorp's Covance division is a global full-service CRO offering clinical trial services, central lab, and FSP models that compete head-to-head with Cytel for biometrics and adaptive trial design work, particularly among large pharma clients.
- Pharmaron: Pharmaron is a China-headquartered CRO/CDMO offering integrated drug discovery, clinical, and biostatistics services — comparable to Cytel's end-to-end biometrics and biostatistics services, particularly relevant as Cytel expands in APAC.
- Charles River Laboratories: Charles River provides preclinical and clinical research services including biostatistics and trial design support, overlapping with Cytel's project-based analytics and consulting offerings, though its center of gravity is preclinical.
- Parexel International: Parexel is a global CRO offering biometrics, biostatistics, FSP, and adaptive trial expertise post-its 2021 EQT-led take-private, competing with Cytel for mid-sized biotech and large pharma biometrics engagements.
Direct peers
- Medidata Solutions (Dassault Systèmes): Medidata provides clinical trial technology platforms (Rave EDC, Medidata AI) and competes directly with Cytel's East Horizon and trial implementation software for sponsor design and simulation workflows, though Medidata is more EDC/CTMS-focused while Cytel emphasizes adaptive design.
- Veeva Systems: Veeva's Vault CDMS and Vault CTMS compete with Cytel's clinical trial software, and Veeva's broader life sciences CRM and regulatory solutions overlap with Cytel's RWE and regulatory strategy offerings among pharma sponsors.
- Berry Consultants: Berry Consultants is a specialized statistical consulting firm pioneering adaptive trial design and Bayesian methods — directly comparable to Cytel's core methodological DNA and competing for adaptive trial design consulting engagements.
Emerging players
- Clario: Clario (formed from ERT and Bioclinica) provides clinical trial technology including EDC, eCOA, and imaging with growing AI/biostatistics capabilities — adjacent to Cytel's software stack and competing in some sponsor technology selections.
Market position
Strengths5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Cytel social profiles
Digital presenceCytel financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cytel leadership team
Management profileNumber of profiles
Profiles24 records
Cytel subsidiaries and ownership
Company hierarchySubsidiaries3 records
Cytel funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cytel M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cytel
What does Cytel do?
Cytel is a data-science CRO that sells proprietary clinical trial design and simulation software (East Horizon, StatXact, Solara, Enforesys, LiveSLR) alongside professional services including adaptive trial design consulting, biostatistics, real-world evidence generation, regulatory strategy, and functional service provider (FSP) staffing for pharmaceutical, biotech, and academic research clients.
Is Cytel a public or private company?
Cytel is a private company. It is classified as private equity controlled and is currently operating.
When was Cytel founded?
Cytel was founded in 1987. It employs 501 to 1,000 people.
Where is Cytel based?
Cytel is headquartered in Cambridge, United States, in the North America region.
How does Cytel make money?
Four revenue lines are on record. Functional Service Provider (FSP) is the primary driver. The others are project-Based Analytical Services, software Licensing and strategic Consulting.
Who are Cytel's main competitors?
Broad incumbents on record are IQVIA, ICON plc, Labcorp (Covance Drug Development), Pharmaron, Charles River Laboratories and Parexel International. Direct peers are Medidata Solutions (Dassault Systèmes), Veeva Systems and Berry Consultants. Clario is listed as an emerging player.
Does Cytel have an API?
No public API is recorded for Cytel.
What industry is Cytel in?
Cytel's product category is Clinical Trial Design Software & CRO Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAD, Clinical Trial Management Systems (CTMS). Its NAICS code is 54171 and its SIC code is 8731.